>

IDEXX Reports Second Quarter Earnings

EPS Misses Estimates, Revenue Grows

IDEXX Laboratories, Inc. (NASDAQ: IDXX) reported second quarter 2024 earnings per share (EPS) of $2.44, missing the analyst estimate of $2.89.

Second quarter revenue was $964 million, an increase of 7% year-over-year. The increase was driven by a 10% organic growth in Companion Animal Group (CAG). CAG reported revenue of $366.1 million for the full year, an increase of 9% as reported and 10% organically driven by 10.5% organic growth in CAG.

IDEXX will host a conference call to discuss the second quarter results on August 6, 2024, at 8:30 AM ET.